Panacea Innovation Ltd

Track

Insider profile

Performance

Overall performance
2.2
Performance over holding periods
4.2
30 days 90 days 120 days
Average return 7% 8.2% 15.1%
Success rate 85% 68% 82%
Transactions
4 50% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Performance for realised trades
4.4
Average return -47%
Success rate 73%
Average holding period 220
Transactions 28
Ranking by realised performance
Panacea Innovation Ltd's trades of Atara Biotherapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
6.91
Quantity 80,000
Value US$552,800
Transaction date
Proposed sale
Price
6.91
Quantity 54,000
Value US$373,140
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-05-11 2026-05-07
S Sale
22,056 -44.4%
409.63
US$2,619,371 		22,056 -44.4% 409.63 US$2,619,371
2026-05-07 2026-05-07
PrS Proposed sale
89,658
106.15
US$130,341 		89,658 106.15 US$130,341
2026-01-14 2026-01-12
S Sale
65,938 -17.7%
372.21
US$3,971,090 		65,938 -17.7% 372.21 US$3,971,090
2026-01-12 2026-01-12
PrS Proposed sale
20,554
5.88
US$120,858 		20,554 5.88 US$120,858
2026-01-12 2026-01-12
PrS Proposed sale
20,000
5.88
US$117,600 		20,000 5.88 US$117,600
2026-01-12 2026-01-12
PrS Proposed sale
40,000
5.88
US$235,200 		40,000 5.88 US$235,200
2025-11-24 2025-11-24
PrS Proposed sale
2,000,000
3.00
US$6,000,000 		2,000,000 3.00 US$6,000,000
2025-08-19 2025-08-15
B Purchase
55,000 +4.1%
12.19
US$670,422 		55,000 +4.1% 12.19 US$670,422
2025-07-21 2025-07-17
B Purchase
19,335 +1.5%
9.64
US$186,372 		19,335 +1.5% 9.64 US$186,372
2024-03-05 2024-03-05
PrS Proposed sale
80,000
6.91
US$552,800 		80,000 6.91 US$552,800
2024-03-05 2024-03-05
PrS Proposed sale
54,000
6.91
US$373,140 		54,000 6.91 US$373,140